Out-license Agreements - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended						3 Months Ended		12 Months Ended
	Aug. 31, 2024	Jul. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Oct. 31, 2021	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2022
License Collaboration And Manufacturing Agreements [Line Items]
Revenue							$ 98,149	$ 27,357
Deferred revenue, revenue recognized							75,500
Pierre Fabre Commercialization Agreement
License Collaboration And Manufacturing Agreements [Line Items]
Upfront cash payment received			$ 20,000			$ 45,000
Milestone payments				$ 40,000				20,000	$ 40,000
Additional milestone payments		$ 20,000					40,000
Royalty eligible to receive term after first commercial sale			12 years			12 years
Payments received from sale of inventory	$ 15,500
Determined upfront payment constituted entire consideration included in transaction price						$ 45,000
Development or sales-based milestone payments earned or received				$ 40,000	$ 30,000
Pierre Fabre Commercialization Agreement | Maximum [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Aggregate milestone payments entitle to receive upon achieving certain regulatory and commercial milestones						$ 308,000	550,000
HCRx Agreement [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Proceeds from sale of future royalties, gross							$ 31,000		$ 31,000
Minimum cash repayment							185.00%
Maximum cash repayment							250.00%
AR Commercialization Agreement [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Additional Upfront Payment Included inTransaction Price							$ 20,000
Regulatory Milestone		$ 20,000						20,000
Costs Incurred Relatedto Performance Obligations Includedin R&D							$ 7,100	$ 12,300